HistoSonics picks up $54 mln Series C
Ann Arbor, Michigan-based HistoSonics, a developer of a non-invasive robotics platform and novel beam therapy, has raised $54 million in Series C financing. Varian Medical Systems Inc led the round with participation from other investors that included Johnson & Johnson Innovation - JJDC, Inc, Lumira Ventures, Venture Investors and the State of Wisconsin Investment Board.
11 April 2019•1 min read
